Skip to main content

Clinical Epigenetics of COVID-19

New Content ItemEdited by Georges Herbein

In response to the Coronavirus pandemic, Clinical Epigenetics is welcoming COVID-19 related manuscripts, and will handle these with priority.  Along with our Editors-in-Chief, Section Editor Georges Herbein will handle submissions and helm a solid collection of papers with strong and innovative scientific value.

This collection of articles has not been sponsored and articles have undergone the journal’s standard peer-review process. 

Please find out more about our journal and its policies, here. Submission guidelines can be found here, and please submit to the series via our submission system (there will be a field for which you can indicate if you are submitting to this series).

  1. There are no prior reports that compare differentially methylated regions of DNA in blood samples from COVID-19 patients to samples collected before the SARS-CoV-2 pandemic using a shared epigenotyping platfor...

    Authors: Joseph Balnis, Andy Madrid, Kirk J. Hogan, Lisa A. Drake, Hau C. Chieng, Anupama Tiwari, Catherine E. Vincent, Amit Chopra, Peter A. Vincent, Michael D. Robek, Harold A. Singer, Reid S. Alisch and Ariel Jaitovich

    Citation: Clinical Epigenetics 2021 13:118

    Content type: Research

    Published on:

  2. Epigenetics is a relatively new field of science that studies the genetic and non-genetic aspects related to heritable phenotypic changes, frequently caused by environmental and metabolic factors. In the host,...

    Authors: Sandra Atlante, Alessia Mongelli, Veronica Barbi, Fabio Martelli, Antonella Farsetti and Carlo Gaetano

    Citation: Clinical Epigenetics 2020 12:156

    Content type: Review

    Published on: